Figure 3
- ID
- ZDB-FIG-221226-188
- Publication
- Silva et al., 2022 - Therapeutic Potential of Deflamin against Colorectal Cancer Development and Progression
- Other Figures
- All Figure Page
- Back to All Figure Page
Migration and invasion of CRC cell lines HCT116, HT-29, and SW480 upon treatment with deflamin: (A) Analysis of migration by the wound healing assay of human CRC cell lines HCT116, HT-29 and SW480 treated with deflamin for 48 h and its corresponding quantification (%) (n = 3). (B) 3D spheroid invasion assay of human CRC cell lines HCT116, HT-29, and SW480 treated with deflamin and the corresponding quantification (number of absolute invasive cells). The number of spheroids analyzed is indicated in the graphs. Statistical analysis was performed as described in the Statistical Analysis section (*, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001). |